{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:03:33Z","timestamp":1793174613655,"version":"4.5.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Vector Borne Dis"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/0972-9062.302039","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T13:01:17Z","timestamp":1607000477000},"page":"351","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and laboratory evaluation of cured and non-cured patients with cutaneous leishmaniasis treated by Glucantime"],"prefix":"10.4103","volume":"56","author":[{"given":"I","family":"Sharifi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Ezatkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Babaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MR","family":"Baneshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Zolala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kermanizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Keyhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ES","family":"Dezaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MR","family":"Aflatoonian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Aflatoonian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bamorovat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0972-9062.302039-1","first-page":"e35671","volume-title":"Leishmaniasis worldwide and global estimates of its incidence","author":"Alvar","year":"2012","journal-title":"PloS One"},{"key":"key-10.4103\/0972-9062.302039-2","first-page":"286","volume-title":"Leishmaniasis in high-burden countries: An epidemiological update based on data reported in 2014","author":"WHO","year":"2016","journal-title":"Wkly EpidemiolRec"},{"key":"key-10.4103\/0972-9062.302039-3","unstructured":"WHO. Leishmaniases C. Control of the leishmaniases: Report of a meeting of the WHO Expert Commitee on the Control of Leishmaniases, March 22-26 2010. WHO Tech Rep Ser. Geneva: World Health Organization 2010:xii. PubMed PMID: 21485694."},{"key":"key-10.4103\/0972-9062.302039-4","first-page":"305","volume-title":"Leishmaniasis: Current situation and new perspectives","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"key-10.4103\/0972-9062.302039-5","first-page":"e0005739","volume-title":"A new perspective on cutaneous leishmaniasis\u2014Implications for global prevalence and burden of disease estimates","author":"Bailey","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.4103\/0972-9062.302039-6","first-page":"e0004545","volume-title":"Old world cutaneous leishmaniasis and refugee crises in the Middle East and North Africa","author":"Du","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.4103\/0972-9062.302039-7","first-page":"1269","volume-title":"The leishmaniases as emerging and reemerging zoonoses","author":"Ashford","year":"2000","journal-title":"Int J Parasitol"},{"key":"key-10.4103\/0972-9062.302039-8","first-page":"4747","volume-title":"Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis\u2014A meta-analysis","author":"Noazin","year":"2009","journal-title":"Vaccine"},{"key":"key-10.4103\/0972-9062.302039-9","first-page":"319","volume-title":"Chemotherapy of leishmaniasis","author":"Croft","year":"2002","journal-title":"Curr Pharmaceutical Design"},{"key":"key-10.4103\/0972-9062.302039-10","first-page":"335, e1","volume-title":"Treatment of acute Old World cutaneous leishmaniasis: A systematic review of the randomized controlled trials","author":"Khatami","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0972-9062.302039-11","first-page":"e0192236","volume-title":"Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran","author":"Bamorovat","year":"2018","journal-title":"PloS One"},{"key":"key-10.4103\/0972-9062.302039-12","first-page":"124","volume-title":"Leishmania tropica isolates from non- healed and healed patients in Iran: A molecular typing and phy- logenetic analysis","author":"Bamorovat","year":"2018","journal-title":"Microbial Pathogenesis"},{"key":"key-10.4103\/0972-9062.302039-13","first-page":"e162","volume-title":"Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishma- nia tropica parasites","author":"Hadighi","year":"2006","journal-title":"PLoSMed"},{"key":"key-10.4103\/0972-9062.302039-14","first-page":"257","volume-title":"Leishmaniasis: Drugs in the clinic, resistance and new developments","author":"Ouellette","year":"2004","journal-title":"Drug Resistance Updates"},{"key":"key-10.4103\/0972-9062.302039-15","first-page":"167","volume-title":"Drug resistance in leishmaniasis","author":"Chakravarty","year":"2010","journal-title":"J Glob InfectDis"},{"key":"key-10.4103\/0972-9062.302039-16","first-page":"849","volume-title":"Drug resistance in Indian visceral leishmaniasis","author":"Sundar","year":"2001","journal-title":"Trop MedIntHealth"},{"key":"key-10.4103\/0972-9062.302039-17","first-page":"399410","volume-title":"Current scenario of drug development for leishmaniasis","author":"Croft","year":"2006","journal-title":"Indian J Med Res"},{"key":"key-10.4103\/0972-9062.302039-18","unstructured":"Shirzadi MR, Gouya MM. National guidelines for cutaneous leishmaniasis surveillance in Iran. Tehran, Iran: Ministry of Health and Medical Education (MoH) Zoonoses Control Department 2012: pp. 1-78."},{"key":"key-10.4103\/0972-9062.302039-19","first-page":"239","volume-title":"The increase in risk factors for leishmaniasis worldwide","author":"Desjeux","year":"2001","journal-title":"Trans R Soc Trop MedHyg"},{"key":"key-10.4103\/0972-9062.302039-20","first-page":"299","volume-title":"A comprehensive review of cutaneous leish- maniasis in Kerman province, southeastern iran-narrative review article","author":"Sharifi","year":"2015","journal-title":"Iran J Public Health"},{"key":"key-10.4103\/0972-9062.302039-21","first-page":"544","volume-title":"Clinical features of anthroponotic cutaneous leishmaniasis in a major focus, southeastern Iran, 1994-2014","author":"Khosravi","year":"2017","journal-title":"Iran JParasitol"},{"key":"key-10.4103\/0972-9062.302039-22","first-page":"848","volume-title":"Treatment of cutaneous leishmania- sis recidivans with a combination of allopurinol and meglumine antimoniate: A clinical and histologic study","author":"Esfandiarpour","year":"2007","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0972-9062.302039-23","first-page":"557","volume-title":"Leishmaniasis recidivans among school children in Bam, southeast Iran, 1994-2006","author":"Sharifi","year":"2010","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0972-9062.302039-24","first-page":"156","volume-title":"The efficacy, relapse and failure in the treatment of anthroponotic cutaneous leishmaniasis with intralesional glucantime along with cryotherapy","author":"Karvar","year":"2016","journal-title":"J Kerman Univ MedSci"},{"key":"key-10.4103\/0972-9062.302039-25","first-page":"1319","volume-title":"Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs","author":"Hadighi","year":"2007","journal-title":"Parasitol Res"},{"key":"key-10.4103\/0972-9062.302039-26","first-page":"12334","volume-title":"Identification of nonresponsive isolates to Glucantime in patients with cutaneous Leishmanaisis in Bam","author":"Pour","year":"2011","journal-title":"JKerman UnivMed Sci"},{"key":"key-10.4103\/0972-9062.302039-27","first-page":"1335","volume-title":"Molecular epidemiology of cutaneous leishmaniasis and heterogeneity of Leishmania major strains in Iran","author":"Mahmoudzadeh","year":"2012","journal-title":"Trop Med Int Health"},{"key":"key-10.4103\/0972-9062.302039-28","first-page":"120","volume-title":"Efficacy of glucan time for treatment of cutaneous leishmaniasis in Central Iran","author":"Mohammadzadeh","year":"2013","journal-title":"J Infect Public Health"},{"key":"key-10.4103\/0972-9062.302039-29","first-page":"33","volume-title":"Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran","author":"Mohebali","year":"2007","journal-title":"Acta Trop"},{"key":"key-10.4103\/0972-9062.302039-30","doi-asserted-by":"crossref","unstructured":"Soleimanifard S, Arjmand R, Saberi S, Hejazi SH. Treatment outcome of the drug-resistant zoonotic cutaneous leishmaniasis by glucantime. AdvancedBiomedRes 2017; 6. pages ??","DOI":"10.4103\/2277-9175.201329"},{"key":"key-10.4103\/0972-9062.302039-31","first-page":"e89043","volume-title":"A prospective cohort study of cutaneous leish- maniasis risk and opium addiction in south eastern Iran","author":"Aflatoonian","year":"2014","journal-title":"PloS One"},{"key":"key-10.4103\/0972-9062.302039-32","first-page":"1113","volume-title":"The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate","author":"Shokri","year":"2012","journal-title":"Parasitol Res"},{"key":"key-10.4103\/0972-9062.302039-33","first-page":"622","volume-title":"Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: Analysis of resistance biomarkers by gene expression profiling","author":"Oliaee","year":"2018","journal-title":"Trop Med Int Health"},{"key":"key-10.4103\/0972-9062.302039-34","first-page":"e02360","volume-title":"Meglumine antimoniate (Glucantime) causes oxidative stress-derived DNA damage in BALB\/c mice infected by Leishmania (Leishmania) infantum","author":"Moreira","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0972-9062.302039-35","first-page":"1760","volume-title":"Comparison of the immune profile of non-healing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection","author":"Ajdary","year":"2000","journal-title":"Infect Immun"},{"key":"key-10.4103\/0972-9062.302039-36","first-page":"581","volume-title":"Cutaneous leishmaniasis: Immune responses in protection and pathogenesis","author":"Scott","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"key-10.4103\/0972-9062.302039-37","first-page":"502","volume-title":"Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis","author":"Pourmohammadi","year":"2011","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"key-10.4103\/0972-9062.302039-38","first-page":"899","volume-title":"Monitoring drug resistance in leishmaniasis","author":"Croft","year":"2001","journal-title":"Trop Med Int Health"},{"key":"key-10.4103\/0972-9062.302039-39","first-page":"216","volume-title":"Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models","author":"Dube","year":"2005","journal-title":"Parasitol Res"},{"key":"key-10.4103\/0972-9062.302039-40","first-page":"1001","volume-title":"Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their in vitro drug susceptibility pattern","author":"Mishra","year":"2013","journal-title":"Parasitol Res"},{"key":"key-10.4103\/0972-9062.302039-41","first-page":"e0004739","volume-title":"Clinical and parasitological features of patients with American cutaneous leishmaniasis that did not respond to treatment with meglumine antimoniate","author":"Perez-Franco","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.4103\/0972-9062.302039-42","first-page":"143","volume-title":"Molecular mechanisms of antimony resistance in Leishmania","author":"Ashutosh,","year":"2007","journal-title":"J Med Microbiol"},{"key":"key-10.4103\/0972-9062.302039-43","first-page":"827","volume-title":"In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: A study of 37 strains collected from patients with visceral leishmaniasis","author":"Faraut-Gambarelli","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0972-9062.302039-44","first-page":"39","volume-title":"J-binding protein 1 and J-binding protein 2 expression in clinical Leishmania major no response-antimonial isolates","author":"Ahmadian","year":"2019","journal-title":"J Parasitic Dis"},{"key":"key-10.4103\/0972-9062.302039-45","first-page":"370","volume-title":"Aquaglyceroporin1 gene expression in antimony resistance and susceptible Leishmania major isolates","author":"Eslami","year":"2016","journal-title":"J Vector Borne Dis"},{"key":"key-10.4103\/0972-9062.302039-46","first-page":"111","volume-title":"Drug resistance in leishmaniasis","author":"Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/0972-9062.302039-47","first-page":"896","volume-title":"Cutaneous leishmaniasis caused by Leishmania tropica in Bikaner, India: Parasite identification and characterization using molecular and immunologic tools","author":"Kumar","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/0972-9062.302039-48","first-page":"68","volume-title":"Phylogenetic structure of Leishmania tropica in the new endemic focus Birjand in East Iran in comparison to other Iranian endemic regions","author":"Karamian","year":"2016","journal-title":"Acta Trop"},{"key":"key-10.4103\/0972-9062.302039-49","first-page":"e 259","volume-title":"Marring leishmaniasis: The stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan","author":"Kassi","year":"2008","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Journal of Vector Borne Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:50:33Z","timestamp":1786733433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0972-9062.302039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["302039"],"URL":"https:\/\/doi.org\/10.4103\/0972-9062.302039","relation":{},"ISSN":["0972-9062"],"issn-type":[{"value":"0972-9062","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}